|
|||||
|
|
Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia |
|
| Authors: | Farhad Ravandi MD Elias Jabbour MD Guillermo Garcia‐Manero MD Gautam Borthakur MD Alessandra Ferrajoli MD Marina Konopleva MD PhD Jan Burger MD PhD Xuelin Huang Xuemei Wang Sherry Pierce Mark Brandt Jennie Feliu Jorge Cortes MD Hagop Kantarjian MD |
| Affiliation: | 1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | elderly acute myeloid leukemia (AML) low intensity maintenance |